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HIV-1 evolution in the envelope gene (env) was analyzed in four asymptomatic antiretroviral therapy naïve patients with typical and slow
disease progression rates. In typical progressors, viral populations were monophyletic and two distinct evolutionary patterns were observed. In
one patient, HIV-1 evolution displayed a strong temporal structure similar to the consistent pattern previously described. In the other, viral
evolution displayed a lack of temporal structure with no increase in genetic heterogeneity and divergence over time. In slow progressors,
several clades were observed in viral populations. However, analysis within the major sub-population revealed the same two evolutionary
patterns described for typical progressors. Synonymous and non-synonymous substitution rate analyses indicated that positive selection was the
major force driving HIV-1 evolution in viral populations with temporal structure, while evolution in viral populations with an atemporal
structure was dominated by genetic drift and purifying selection. These results support the existence of distinct patterns of env evolution in
untreated HIV-1-infected patients.
© 2007 Elsevier Inc. All rights reserved.Keywords: Intra-host HIV evolution; Phylogeny; Temporal structure; Atemporal structure; dN/dS; Recombination; In vivoIntroduction
A consistent model of intra-host HIV-1 evolution has been
previously proposed based on the analysis of the envelope (env)
gene in nine patients with typical clinical disease progression
(Shankarappa et al., 1999). According to this model, during
most of the asymptomatic period intra-host HIV-1 evolution
displays a strong temporal structure, characterized by a constant
replacement of viral lineages and a linear increase in divergence
and heterogeneity of viral quasispecies over time. A recent
analysis of the synonymous (dS) and non-synonymous (dN)⁎ Corresponding author. Fax: +34 91 509 79 19.
E-mail address: clopez@isciii.es (C. López-Galíndez).
0042-6822/$ - see front matter © 2007 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2006.11.039substitutions rates in these data suggests that positive selection
is the primary driving force underlying this temporal evolu-
tionary pattern (Williamson et al., 2005). A similar pattern has
been reported in many other HIV-1 infected adults (Casado et
al., 2001; Liu et al., 1997; Mani et al., 2002; Markham et al.,
1998; Poss et al., 1998; Shankarappa et al., 1998; Shioda et al.,
1997; Troyer et al., 2005; Wolinsky et al., 1996; Zhang et al.,
1997) and children (Ganeshan et al., 1997; Halapi et al., 1997;
Nowak et al., 2002; Salvatori et al., 1997; Strunnikowa et al.,
1995), usually associated with positive selection. This temporal
pattern of intra-host HIV-1 evolution might result from a
process of high viral adaptation rate that occurs when virus
replication coincides with a persistent and continual immune
pressure (Grenfell et al., 2004).
In the present study we performed a longitudinal analysis
of HIV-1 evolution at the C2–V5 region of env gene
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naïve patients with typical and slow disease progression
rates. Our results suggested the existence of two distinct
patterns of intra-host HIV-1 evolution in these patients,
characterized by the presence or absence of a temporal
structure.
Results
Patient characteristics
The short-term viral evolution, during four to six years, was
studied in four HIV-1 asymptomatic naïve patients at the C2–
V5 region in env gene, in samples taken 2 to 16 years after
seroconversion. In general, patients maintained CD4+ cell
numbers above 500 cells/mm3 and plasma RNA viral load
usually bellow 20,000 copies/ml (Fig. 1). Looking at variation
in the CD4+ numbers, patient 59 exhibited a decline of CD4+ T
cells, with a mean decrease rate of about 60 cells/mm3/year
(P=0.0003). Patient 60 showed a sharper decline in the first
years and a mean decrease rate of 53 cells/mm3/year (P=
0.0011). The decreasing trend in CD4+ numbers in these
patients is compatible with the pattern described for typical
progressors (Betts et al., 1999). In contrast, the same analysis in
patients 30 (P=0.3427) and 45 (P=0.5428) did not show such
decline after 14 to 19 years of infection, allowing the
classification of these patients as slow progressors or long
term non-progressors (LTNPs).Fig. 1. Plasma RNA viral load and CD4+ T cell values over time from the first
load versus CD4+ T cell count. Plasma RNA viral loads (copies/ml) are shown o
vertical axis. For samples with an RNA viral load below the detection limit (50
which viral quasispecies were analyzed. Subject identification numbers are given
patients.Phylogenetic analyses
In general, models of nucleotide substitution selected by
Modeltest were quite complex (TVM+G, GTR+I+G, K81uf+
I+G, and TIM+I+G for patients 30, 45, 59, and 60, respec-
tively; see Posada and Crandall, 2001 for a detailed description)
and are described in more detail in the Materials and methods
section. The complexity of the models indicate that the variation
of the substitution rate among sites is an important feature of
HIV-1 evolution, even within patients.
In typical progressors only one major clade was identified
per patient, but two distinct evolutionary patterns were ob-
served. In patient 59, viral evolution showed a strong temporal
structure (“temporal model”) characterized by the progressive
diversification of the env gene over time (Fig. 2a), similar to
the pattern described by Shankarappa et al. (1999). Variants
isolated at earlier time points gave rise to later variants which
were more distant to the MRCA (most recent common
ancestor) than earlier ones. The mean genetic heterogeneity at
the last time point was higher (P<0.001) than at the first one
(Table 1); and the mean genetic divergence exhibited an
increase over time, with a constant annual rate of 1.76%
(P=0.0028) (Fig. 3a).
In contrast, in patient 60 the viral evolutionary pattern was
characterized by the lack of a temporal structure (“atemporal”
model). The variants recovered at a given time point were not
the origin of the virus isolated immediately later, and more
importantly, the viruses isolated at later time points were notvisit in each of the four patients studied. Each point represents plasma viral
n the left vertical axis. CD4+ T cell counts (×106/l) are shown on the right
cp/ml), we assigned a value of 50 cp/ml. Arrows indicate the samples in
in the center of each graph. Graphs are not depicted in the same scale in all
296 G. Bello et al. / Virology 362 (2007) 294–303more distant to the MRCA than viruses isolated earlier (see Fig.
2b). The mean genetic heterogeneity was not significantly
different in the first and last samples (P>0.05) (Table 1), and the
mean genetic divergence did not show a significant linear
increase over time (P=0.2080) (Fig. 3b).
In the LTNPs patients, several well-supported clades were
observed (Figs. 2c and d), as previously noted (Bello et al.,
2004). Up to five clades (a to e) could be identified in patient
30, and three (a to c) in patient 45. According to the dating of
the different clades, some clades represented actively replicat-
ing variants (a, b and c in patient 30, and a in patient 45), while
others constituted ancestral non-replicating strains (d, and e in
patient 30; b and c in patient 45) close in time to the sequences
at seroconversion time (Bello et al., 2004). In each patient, one
clade (designated a) dominated the quasispecies during most of
the follow up (Figs. 2c and d). The phylogenetic analysis within
these major clades revealed the same two evolutionary patterns
described above for the typical progressors. Clade a of patient
30 displayed a temporal structure similar to that described for
patient 59, with a significant increase of the mean heterogeneity
over time (P<0.05) and with a mean annual increase of
divergence rate of 1.2% (P<0.05) (see Table 1 and Fig. 3c). In
contrast, clade a of patient 45 exhibited a lack of temporal
structure similar to that described for patient 60, with no
consistent increase of the mean heterogeneity (P>0.05) and
divergence (P<0.05) over time (see Table 1 and Fig. 3d). All
the subsequent analyses in patients 30 and 45 were carried out
only with the dominant “a” clades.
Recombination analyses
The recombination permutation test was significant for all
patients and time points, and the recombination rate estimates
were similar for most patients (data not shown), suggesting that
the distinct evolutionary patterns are not the result of different
recombination rates.
Selective pressure analyses
In most cases (85%) the dual model of rate variation gave
a lower AIC value than the non-synonymous model, while
63% of the LRTs were significant (P-value<0.05), indicating
that there is a significant dS rate variation within these data
sets. The dN/dS estimates were typically above 1 in patients
30 and 59; but always below 1 in patients 45 and 60 (Table
2). Positively and negatively selected sites were identified at
most time points, but important differences were found
between individuals. In patients 59 and 30, the mean number
of sites under positive selection was generally higher than the
number of sites under negative selection, whereas in patients
45 and 60 the opposite was true (Table 2). The analysis of the
dN and dS divergence (Williamson et al., 2005) clearly
showed that in patients 30 and 59, dN accumulates steadily
over time and at a faster rate than dS, whereas in patients 45
and 60, dN or dS did not accumulate over time (Table 3). In
the tree-based analysis, dN or dS estimates were of smaller
magnitude, although showed similar trends; except for patient30, where no significant accumulation of dN was detected
over time (Table 3).
Discussion
In this study we detected the existence of two distinct
patterns of short-term intra-host HIV-1 evolution in asympto-
matic naïve patients, and described, for the first time, an
evolutionary model without temporal structure.
Intra-host HIV-1 evolution in two patients (59 and 30), one
typical progressor and one LTNP, displayed a strong temporal
structure characterized by the continual replacement of variants
and the progressive increase of the mean viral heterogeneity and
divergence over time consistent with the evolutionary pattern
described by Shankarappa et al. (1999). The mean annual
divergence rate of 1.2% (LTNP 30) and 1.8% (typical
progressor patient 59) was also in agreement with previous
reports (Shankarappa et al., 1999).
In the other two patients (60 and 45), one typical progressor
and one LTNP, intra-host HIV-1 evolution was characterized by
a lack of temporal structure. The viruses detected at later time
points were less heterogeneous and showed lower divergence
from the MRCA than viruses obtained earlier. A similar pattern
of viral evolution has been only previously described in
sequences isolated from latent reservoirs (Gunthard et al.,
1999) or from PBMCs (Frenkel et al., 2003) in patients under
HAART. A weak temporal structure was also previously
described in some naïve patients with extreme disease
progression rates like rapid or non-progressors (Bello et al.,
2005; Ganeshan et al., 1997; Mani et al., 2002; Shioda et al.,
1997; Strunnikowa et al., 1995; Wang et al., 2002; Wolinsky et
al., 1996). In those patients however, the “atemporal” pattern
was associated with highly homogeneous quasispecies; in
contrast to the highly heterogeneity (up to 5%) observed in
quasispecies of patients 45 and 60.
We should note that the fact that virus sampled from the
same patient are linked by a common evolutionary history
violates one the fundamental assumptions of standard
(parametric or nonparametric) statistics used to compare
genetic diversity and divergence between viral samples at
different time points, namely, that data points are indepen-
dent. This lack of independence leads to the underestimation
of standard deviations, making the t-tests or the correlation
tests non-conservative. Indeed, these caveats are operating in
any study describing changes in genetic diversity and
divergence through time within HIV patients. The only
solution would be the use of independent viral lineages,
which could be impossible to obtain from individual HIV
patients. In any case, the differences in diversity and
divergence obtained are clear, and other lines of evidence,
like the shape of the phylogenetic trees, point out in the same
direction, suggesting that the patterns observed represent a
real phenomenon.
We investigated different evolutionary factors which could
be accountable for these two distinct patterns. Recombination
analyses performed suggest that the distinct intra-host evolu-
tionary patterns are not associated with different recombination
297G. Bello et al. / Virology 362 (2007) 294–303rates within patients; however, significant differences between
patterns were observed regarding the contribution of positive
and negative selection. The strong temporal structure of the
HIV-1 evolution in patients 30 (clade a) and 59, was associated
with positive selection operating within and across time points
(dN/dS>1.0), consistent with the notion that the primary driving
force of the temporal evolutionary model is positive selection
(Williamson et al., 2005). The signal for positive selection
across time points in patients 30 and 59 was clearer with the
Williamson's method, which in theory should be less affected
by recombination than tree-based approaches, because it does
not assume a particular phylogenetic structure (Williamson et
al., 2005). In contrast, the lack of temporal structure seen in
patients 45 (clade a) and 60, was associated with negative
selection operating within and across time points (dN/dS<1.0).
Thus, differential host-imposed immune selective pressures
could be the origin of the discordant viral evolutionary patterns
observed in this study.Fig. 2. Maximum likelihood phylogenetic trees for the env gene. Partial HIV-1 PBMC
with reference strains (italic). Sequences are represented with an arbitrary symbol corr
indicate booststrap support (only values greater than 50% are shown). Branch lengtAccording to the phylodynamic models described by
Grenfell et al. (2004), the temporal structure and high viral
adaptation rate seen in patients 30 and 59 could result from the
coincidence of appreciable virus replication with a persistent
medium immune selection pressure. In this situation, HIV-1
chronic infection is sustained by rapid and continuous cycles of
productive infection and cell death of the activated CD4+ Tcells
(Ho et al., 1995; Perelson et al., 1996; Wei et al., 1995) due to
the constant rise and selection of immune escape variants
(adaptive model of evolution) (Lukashov and Goudsmit, 1998;
Wolinsky et al., 1996).
The lack of temporal structure seen in patients 45 and 60 is
more compatible with a pattern of neutral evolution as
suggested by dN/dS ratios (<1) (Table 2 and 3). This atem-
poral model could result from the coincidence of appreciable
virus replication with low immune pressure (Grenfell et al.,
2004). Such immunodeficient situation in patients 45 and 60
could correspond to the period where the clinical symptoms-derived gp120 env sequences of patients 59 (a), 60 (b), 30 (c), and 45 (d), along
esponding to the sampling year, as indicated in the key. Numbers at branch nodes
hs are drawn to scale.
Fig. 2 (continued).
298 G. Bello et al. / Virology 362 (2007) 294–303arise or AIDS. However, this is unlikely because patients 45
and 60 were away from the AIDS period and they did not
show any clinical symptom of disease progression, maintain-
ing low RNA viral loads and remaining therapy naïve during
the follow-up (Fig. 1). Instead, this “atemporal” structure
might result from the coincidence of appreciable virus
replication with a persistent high immune pressure able to
reduce the rise and selection of immune escape variants. Under
this viral replication model the intra-host HIV-1 evolution will
be driven principally by genetic drift (Frost et al., 2001; Plikat
et al., 1997). In this situation, the persistent virus replication
would be mainly sustained by the constant activation of newvariants from the latently infected CD4+ T cell reservoir
(Proximal Activation and Transmission, or PAT model)
(Grossman et al., 1998; Grossman et al., 1999). According
to the PAT model, sequences derived from later points should
not necessarily replicate through more generations and
accumulate more changes than variants isolated earlier, leading
to a lack of temporal structure and no consistent increase in dS
divergence.
We did not find any association between the evolutionary
pattern, time since seroconversion and disease progression rate.
The same pattern of viral evolution was observed in patients
with different disease progression rates and at different times
Table 1
Nucleotide heterogeneity analyses at the first and last time points of the follow-up
Patient Heterogeneity a P
First time point Last time point
59 2.4±1.3 6.7±3.0 <0.001
60 5.5±2.1 5.5±2.1 >0.05
30 (clade a) 3.2±1.6 4.3±2.1 <0.05
45 (clade a) 2.4±1.3 2.4±2.1 >0.05
a Mean nucleotide distance between all pair-wise comparisons of sequences
within each patient (%±S.D.), assessed at the first and last time point of the
follow-up.
Table 2
dN and dS diversities within time points
Time point REL estimates of dN/dS
P30 (clade a) P45 (clade a) P59 P60
1 1.20 0.93 0.86 0.53
2 1.51 0.99 1.19 0.76
3 1.02 0.64 1.53 0.89
4 1.31 0.58 2.04 0.50
5 0.61
6 0.88
Mean 1.26 0.77 1.40 0.67
Time point Number of sites under positive or negative (in parentheses)
selection
P30 (clade a) P45 (clade a) P59 P60
1 14 (6) 1 (4) 32 (3) 11 (12)
2 0 (0) 0 (18) 24 (2) 13 (23)
3 18 (1) 8 (3) 7 (11) 0 (20)
4 5 (16) 0 (16) 8 (11) 29 (8)
5 5 (16)
6 0 (16)
Total 37 (23) 14 (73) 71 (27) 53 (63)
299G. Bello et al. / Virology 362 (2007) 294–303after seroconversion (patients 30 and 59, or patients 45 and 60);
while distinct patterns were detected in patients with similar
disease stages and at similar times since seroconversion
(patients 59 and 60). However, the viral load observed in
patients 30 and 59 at the last time points could indicate an
association of temporal structure with higher risk of failure of
viral replication control (Fig. 1), resulting from the rapid and
constant selection of immune escape variants.
It is important to indicate that both patterns of viral evolution
were observed in the global population in patients 59 and 60,
but only in the major clades in patients 30 and 45. This could
result from the co-existence of viral variants originated from
different compartments (organs, tissues, and cell types), and/or
latent viral reservoirs, which would produce large fluctuations
in the genetic distance estimates (Nickle et al., 2003). The
different viral dating of clades for patients 30 and 45 (Bello et
al., 2004) is fully consistent with this hypothesis. Discontinuous
HIV-1 intra-host evolutionary patterns associated to the co-Fig. 3. Nucleotide divergence regression analysis. The mean nucleotide distance fro
methods) was calculated for each sampling year in the four patients. Error bars indica
of regression, and P values, are indicated in each graph.evolution of several distinct lineages (Casado et al., 2001;
Holmes et al., 1992; Simmonds et al., 1991), or to the
reappearance of founder ancestral viral variants (Karlsson et
al., 1999; Nowak et al., 2002; Ostrowski et al., 1998), has been
also previously observed in other patients.
In conclusion, our data suggests that, apart from the
consistent intra-host HIV-1 evolutionary pattern previously
described, a second pattern without temporal structure could bem a given time point to the reconstructed MRCA sequence (see Materials and
te standard errors of the mean. Subject identification numbers, slope, coefficient
Table 3
dN and dS divergence from the MRCA
Time
point
P30 (clade a) P45 (clade a) P59 P60
dN dS dN dS dN dS dN dS
Divergence analysis following Williamson et al. (2005)
1 0.0172 0.0206 0.0108 0.0197 0.0148 0.0165 0.0242 0.0377
2 0.0365 0.0276 0.0272 0.0655 0.0464 0.0156 0.0411 0.0489
3 0.0407 0.0268 0.0327 0.0647 0.0684 0.0330 0.0420 0.0375
4 0.0535 0.0306 0.0220 0.0369 0.0982 0.0561 0.0448 0.0481
5 0.0355 0.0567
6 0.0277 0.0480
Tree-based divergence analysis
1 0.0145 0.0074 0.0053 0.0199 0.0049 0.0073 0.0161 0.0179
2 0.0043 0.0076 0.0072 0.0114 0.0164 0.0080 0.0121 0.0170
3 0.0045 0.0074 0.0088 0.0122 0.0300 0.0197 0.0129 0.0123
4 0.0113 0.0186 0.0076 0.0209 0.0694 0.0368 0.0101 0.0152
5 0.0110 0.0145
6 0.0065 0.0107
300 G. Bello et al. / Virology 362 (2007) 294–303observed in some untreated asymptomatic patients. These two
different patterns seem to be result of differential host-imposed
selective pressures. The long term evolution and the clinical
implications of the different patterns remain to be clarified.
Materials and methods
Study subjects
Four HIV-1-infected individuals, three homosexual and one
intravenous drug user patients (patient 59) from an outpatient
clinic (Centro Sanitario Sandoval, IMSALUD, Madrid) were
selected because they remained asymptomatic without antire-
troviral therapy during the analyzed period. CD4+ and vRNA
loads are summarized in Fig. 1. Patients 59 and 60 were typical
progressors, whereas patients 30 and 45 were considered long-
term non-progressors (LTNPs).
Quantification of RNA plasma viral load
Plasma HIV-1 RNA was quantified with the Amplicor HIV
Monitor test kit with a detection limit of 500 copies/ml for early
(before 1998) and 50 copies/ml for late samples (Roche
Diagnostics Systems, Somerville, NJ) following manufacturer's
instructions.
Purification, PCR amplification and quantification of viral
DNA
Peripheral blood mononuclear cells (PBMCs) were obtained
as described in Casado et al. (2001) and viral DNAwas obtained
from 1×107 cells by a standard phenol extraction method. PCR
amplification conditions were those described in Casado et al.
(2001). DNAviral load was determined as described in Rodrigo
et al. (1997) in the same nested PCR used to amplify the C2–C5
gp120 region. To avoid genetic bottlenecking, first PCR
included at least 20 copies of viral DNA which used primers
91ECU (5′-CTTAGGCATCTCCTATGGC-3′, 5956–5974HXB2 position) and 22ED (Casado et al., 2001). Second PCR
included 1 μl of the first PCR products and primers 27EU
(Casado et al., 2001) and 96ED (5′-AGACAATAATTGTCT-
GGCCTGTACCGT-3′, 7862–7836 HXB2 position). When a
low DNA viral load did not allow the simultaneous amplifica-
tion of at least 20 copies, two to five first-round PCRs were
pooled according to the DNA load to prevent the loss of
sequence heterogeneity, and 5 μl of this mixture were used in
the second PCR.
Cloning and sequencing
Two microliters of the nested PCR products were ligated into
the pCR 2.1 plasmid and cloned according to the TA Cloning kit
instructions (Invitrogen, Carlsbad, Calif.). An average of 17
clones (range 11–20 clones) per time point were sequenced with
primer 27EU using the ABI PRISM Dye Terminator reaction kit
(Perkin-Elmer, Norwalk, Conn.) according to manufacturer's
instructions in an ABI PRISM 377 automated sequencer
(Perkin-Elmer, Norwalk, Conn.).
Phylogenetic analyses
All nucleotide sequences included a fragment of 614-bp of
the env gene, spanning from the distal portion of C2 to the
proximal portion of C5 (nucleotides 7068 to 7682 in HXB2
clone). Nucleotide sequences were aligned using CLUSTAL X
(Thompson et al., 1994) and revised by eye. All positions with
gaps were excluded from the analysis. For each patient, best-fit
models of nucleotide substitution were selected according to
the Akaike Information Criterion (AIC) (Akaike, 1974) with
Modeltest 3.6 (Posada and Buckley, 2004; Posada and
Crandall, 1998). The model selected were TVM+G (transver-
sional model with a rate variation among sites) for patient 30,
GTR+G+I model (general time reversible plus invariable sites
and rate variation among sites) for patient 45, K81uf+I+G
model (two transversions—parameter model 1 with unequal
frequencies plus invariable sites and rate variation among sites)
for patient 59 and TIM+I+G (transitional model plus
invariable sites and rate variation among sites) for patient 60
(see Posada and Crandall, 2001 for details on these models).
Maximum likelihood (ML) trees were estimated under the best-
fit model of nucleotide substitution using the searching
algorithm implemented in Phyml v.2.4.1 (Guindon et al.,
2005), starting the search from a BIONJ tree (Gascuel, 1997).
Phylogenetic confidence was assessed by bootstrap (Felsen-
stein, 1988) with 1000 replicates. Distinct clades were defined
for patients 30 and 45, usually supported by high bootstrap
values (>75%). The mean inter-clades nucleotide distances
were high (5% to 12%). These clades were also confirmed with
the help of the PAQ program as described in Baccam et al.
(2001).
Genetic distances analyses
Genetic distances within each patient were estimated by ML
under the best-fit model of nucleotide substitution. To estimate
301G. Bello et al. / Virology 362 (2007) 294–303viral heterogeneity at a given time point, we determined the
mean and standard error of the pairwise nucleotide distances
between all sequences. For viral divergence, we determined the
mean and standard deviation of the pairwise nucleotide distances
between all sequences from this time point and the most recent
common ancestor sequence (MRCA) of the patient, calculated as
the consensus sequence of the earliest sample. In viral
quasispecies with multiple divergent clades, the MRCA
sequence was inferred using only the nucleotide sequences at
the earliest sample included in the major clade.
Recombination analyses
We estimated the recombination rate (4Nr, where N is the
effective population size and r is the recombination rate per
gene per generation) with the composite likelihood estimator
(CLE) (McVean et al., 2002), implemented in Pairwise program
included in the LDhat package, available at http://www.stats.
ox.ac.uk/∼mcvean/LDhat/. The statistical significance of these
estimates was assessed through a likelihood permutation test
with 1000 replicates (McVean et al., 2002).
Selection analyses
We used several strategies in order to study the selective
pressures acting on these patients.
Synonymous rate variation
We applied a test for the presence of variation in the rate of
synonymous substitution per synonymous site (dS) within each
patient and time point using the non-synonymous and dual
models with general discrete distributions as implemented in the
web server DataMonkey (Pond and Frost, 2005). In short, the
non-synonymous model allows only for variation in the rate of
non-synonymous substitution per non-synonymous site (dN)
across sites, while the dual model allows for independent rate
distributions both for dN and dS across sites (Pond and Muse,
2005). Using 3 non-synonymous and 3 synonymous rate
categories these two models are nested and a χ2 distribution
with 4 degrees of freedom can be used to compute the P-values
for a likelihood ratio test (LRT) contrasting these two models.
We also computed the AIC for each model.
Non-synonymous and synonymous rates within time points
For each patient and time point we ran a random effect
likelihood (REL) analysis (Pond and Frost, 2005) using the
DataMonkey server. This analysis provides dN and dS
expectations by fitting codon models by ML. In addition, this
analysis also identifies sites under positive and negative
selection through an empirical Bayesian procedure. This
method allows for rate heterogeneity both in synonymous and
non-synonymous rates, reducing the chances for misidentifica-
tion of positively selected sites (Pond and Muse, 2005).
Non-synonymous and synonymous rates across time points
To analyze the evolution of the dN/dS ratio across time for
each patient we used two independent approaches. First wemeasured dS and dN divergence through time as described by
Williamson et al. (2005). The MRCA in each patient was
approximated as the consensus sequence at the earliest sample.
Conveniently, this method uses the temporal information
contained in the longitudinal samples to correct for saturation
and to identify the evolutionary path between codons that
differ at more than one position. In addition, because it does
not assume a particular phylogenetic structure, it has been
suggested to be less affected by recombination than other
methods (Williamson et al., 2005). Second, we performed a
phylogenetic-based analysis of dS and dN divergence. First we
estimated a ML haplotype tree for each patient with Phyml
using the best-fit model of nucleotide substitution selected by
Modeltest. We then estimated the dN and dS rates for each
branch under a Muse and Gaut codon model (Muse, 1996)
crossed with a time reversible model (MG95×REV) in
HYPHY (Pond et al., 2005). Finally, we used HYPHY to
calculate the mean dN or dS path (the sum of branch lengths)
from the sequences sampled at a given time point to the root
of the patient tree, resulting in maximum likelihood estimates
of mean dN and dS divergence from the MRCA at each time
point.
Statistical analyses
Unpaired Student's t-tests were used to compare group
means. All statistical analyses were carried out with GraphPad
Prism version 2.01 programs (GraphPad Software Incorporated).
Acknowledgments
We want to thank Sergei L. Kosakovsky Pond for his
generous help with HYPHY, and to Scott Williamson for
providing us with his code for the divergence analysis. This
work was supported by grants SAF 2002/626, SAF 2003/04987,
SAF 2005/03833, by the Plan Nacional del SIDA and in part by
the “Red Tematica Cooperativa de Investigación en SIDA (Red
de grupos 173) del FISss”. G.B. was supported by a fellowship
from AECI (MUTIS program) and from Instituto Carlos III. A.
C-R and D.P were supported by grant R01-GM66276 from the
US NIH. DP is also supported by grant BFU2004-02700 of the
SpanishMinistry of Education and Science and by the “Ramón y
Cajal” program of the Spanish government.
Gene accession numbers: AY497948-AY498055, AY498071–
AY498168, AY498227–AY498346, EF118762–EF118806.References
Akaike, H., 1974. A new look at the statistical model identification. IEEE Trans.
Automat. Contr. 19, 716–723.
Baccam, P., Thompson, R.J., Fedrigo, O., Carpenter, S., Cornette, J.L., 2001.
PAQ: Partition Analysis of Quasispecies. Bioinformatics 17 (1), 16–22.
Bello, G., Casado, C., Garcia, S., Rodriguez, C., del Romero, J., Lopez-
Galindez, C., 2004. Co-existence of recent and ancestral nucleotide
sequences in viral quasispecies of human immunodeficiency virus type 1
patients. J. Gen. Virol. 85 (Pt. 2), 399–407.
Bello, G., Casado, C., Sandonis, V., Alonso-Nieto, M., Vicario, J.L., Garcia, S.,
Hernando, V., Rodriguez, C., Romero, J.d., Lopez-Galindez, C., 2005. A
302 G. Bello et al. / Virology 362 (2007) 294–303subset of human immunodeficiency virus type 1 long-term non-progressors
is characterized by the unique presence of ancestral sequences in the viral
population. J. Gen. Virol. 86 (2), 355–364.
Betts, M.R., Krowka, J.F., Kepler, T.B., Davidian, M., Christopherson, C.,
Kwok, S., Louie, L., Eron, J., Sheppard, H., Frelinger, J.A., 1999.
Human immunodeficiency virus type 1-specific cytotoxic T lymphocyte
activity is inversely correlated with HIV type 1 viral load in HIV type 1-
infected long-term survivors. AIDS Res. Hum. Retroviruses 15 (13),
1219–1228.
Casado, C., Garcia, S., Rodriguez, C., del Romero, J., Bello, G., Lopez-
Galindez, C., 2001. Different evolutionary patterns are found within human
immunodeficiency virus type 1-infected patients. J. Gen. Virol. 82 (Pt. 10),
2495–2508.
Felsenstein, J., 1988. Phylogenies from molecular sequences: inference and
reliability. Annu. Rev. Genet. 22, 521–565.
Frenkel, L.M., Wang, Y., Learn, G.H., McKernan, J.L., Ellis, G.M., Mohan,
K.M., Holte, S.E., De Vange, S.M., Pawluk, D.M., Melvin, A.J., Lewis, P.F.,
Heath, L.M., Beck, I.A., Mahalanabis, M., Naugler, W.E., Tobin, N.H.,
Mullins, J.I., 2003. Multiple viral genetic analyses detect low-level human
immunodeficiency virus type 1 replication during effective highly active
antiretroviral therapy. J. Virol. 77 (10), 5721–5730.
Frost, S.D., Dumaurier, M.J., Wain-Hobson, S., Brown, A.J., 2001. Genetic drift
and within-host metapopulation dynamics of HIV-1 infection. Proc. Natl.
Acad. Sci. U.S.A. 98 (12), 6975–6980.
Ganeshan, S., Dickover, R., Korber, B.T.M., Bryson, Y.J., Wolinsky, S.M.,
1997. Human immunodeficiency virus type 1 genetic evolution in
children with different rates of development of disease. J. Virol. 71,
663–677.
Gascuel, O., 1997. BIONJ: an improved version of the NJ algorithm based on a
simple model of sequence data. Mol. Biol. Evol. 14 (7), 685–695.
Grenfell, B.T., Pybus, O.G., Gog, J.R., Wood, J.L.N., Daly, J.M., Mumford,
J.A., Holmes, E.C., 2004. Unifying the epidemiological and evolutionary
dynamics of pathogens. Science 303 (5656), 327–332, doi:10.1126/
science.1090727.
Grossman, Z., Feinberg, M.B., Paul, W.E., 1998. Multiple modes of cellular
activation and virus transmission in HIV infection: a role for chronically and
latently infected cells in sustaining viral replication. Proc. Natl. Acad. Sci.
U.S.A. 95 (11), 6314–6319.
Grossman, Z., Polis, M., Feinberg, M.B., Levi, I., Jankelevich, S., Yarchoan, R.,
Boon, J., de Wolf, F., Lange, J.M., Goudsmit, J., Dimitrov, D.S., Paul, W.E.,
1999. Ongoing HIV dissemination during HAART. Nat. Med. 5 (10),
1099–1104.
Guindon, S., Lethiec, F., Duroux, P., Gascuel, O., 2005. PHYML Online—A
web server for fast maximum likelihood-based phylogenetic inference.
Nucleic Acids. Res. 33, W557–W559 (Web Server issue).
Gunthard, H.F., Frost, S.D., Leigh-Brown, A.J., Ignacio, C.C., Kee, K.,
Perelson, A.S., Spina, C.A., Havlir, D.V., Hezareh, M., Looney, D.J.,
Richman, D.D., Wong, J.K., 1999. Evolution of envelope sequences of
human immunodeficiency virus type 1 in cellular reservoirs in the setting of
potent antiviral therapy. J. Virol. 73 (11), 9404–9412.
Halapi, E., Leitner, T., Jansson, M., Scarlatti, G., Orlandi, P., Plebani, A.,
Romiti, L., Albert, J., Wigzell, H., Rossi, P., 1997. Correlation between HIV
sequence evolution, specific immune response and clinical outcome in
vertically infected infants. AIDS 11 (14), 1709–1717.
Ho, D.D., Neumann, A.U., Perelson, A.S., Chen, W., Leonard, J.M., Markowit,
M., 1995. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1
infection. Nature 373, 123–126.
Holmes, E.C., Zhang, L.Q., Simmonds, P., Ludlam, C.A., Brown, A.J.L., 1992.
Convergent and divergent sequence evolution in the surface envelope
glycoprotein of human immunodeficiency virus type 1 within a single
infected patient. Proc. Natl. Acad. Sci. U.S.A. 89, 4835–4839.
Karlsson, A.C., Gaines, H., Sallberg, M., Lindback, S., Sonnerborg, A., 1999.
Reappearance of founder virus sequence in human immunodeficiency virus
type 1-infected patients. J. Virol. 73 (7), 6191–6196.
Liu, S.-H., Schacker, T., Musey, L., Shriner, D., McElrath, M.J., Corey, L.,
Mullins, J.I., 1997. Divergent patterns of progression to AIDS after infection
from the same source: human immunodeficiency virus type 1 evolution and
antiviral responses. J. Virol. 71, 4284–4295.Lukashov, V.V., Goudsmit, J., 1998. HIV heterogeneity and disease progression
in AIDS: a model of continuous virus adaptation. AIDS 12 (Suppl A),
S43–S52.
Mani, I., Gilbert, P., Sankale, J.L., Eisen, G., Mboup, S., Kanki, P.J., 2002.
Intrapatient diversity and its correlation with viral setpoint in human
immunodeficiency virus type 1 CRF02_A/G-IbNG infection. J. Virol. 76
(21), 10745–10755.
Markham, R.B., Wang, W.C., Weisstein, A.E., Wang, Z., Munoz, A., Templeton,
A., Margolick, J., Vlahov, D., Quinn, T., Farzadegan, H., Yu, X.F., 1998.
Patterns of HIV-1 evolution in individuals with differing rates of CD4 T cell
decline. Proc. Natl. Acad. Sci. U.S.A. 95 (21), 12568–12573.
McVean, G., Awadalla, P., Fearnhead, P., 2002. A coalescent-based method for
detecting and estimating recombination from gene sequences. Genetics 160
(3), 1231–1241.
Muse, S.V., 1996. Estimating synonymous and nonsynonymous substitution
rates. Mol. Biol. Evol. 13 (1), 105–114.
Nickle, D.C., Jensen, M.A., Shriner, D., Brodie, S.J., Frenkel, L.M., Mittler,
J.E., Mullins, J.I., 2003. Evolutionary indicators of human immunodefi-
ciency virus type 1 reservoirs and compartments. J. Virol. 77 (9),
5540–5546.
Nowak, P., Karlsson, A.C., Naver, L., Bohlin, A.B., Piasek, A., Sonnerborg, A.,
2002. The selection and evolution of viral quasispecies in HIV-1 infected
children. HIV Med. 3 (1), 1–11.
Ostrowski, M.A., Krakauer, D.C., Li, Y., Justement, S.J., Learn, G., Ehler, L.A.,
Stanley, S.K., Nowak, M., Fauci, A.S., 1998. Effect of immune activation on
the dynamics of human immunodeficiency virus replication and on the
distribution of viral quasispecies. J. Virol. 72 (10), 7772–7784.
Perelson, A.S., Neumann, A.U., Markowitz, M., Leonard, J.M., Ho, D.D., 1996.
HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and
viral generation time. Science 271 (5255), 1582–1586.
Plikat, U., Nielsen-Struwe, K., Meyerhans, A., 1997. Genetic drift can dominate
short-term human immunodeficiency virus type 1 nef quasispecies evolution
in vivo. J. Virol. 71, 4233–4240.
Pond, S.L., Frost, S.D., 2005. DataMonkey: rapid detection of selective
pressure on individual sites of codon alignments. Bioinformatics 21 (10),
2531–2533.
Pond, S.K., Muse, S.V., 2005. Site-to-site variation of synonymous substitution
rates. Mol. Biol. Evol. 22 (12), 2375–2385.
Pond, S.L., Frost, S.D., Muse, S.V., 2005. HyPhy: hypothesis testing using
phylogenies. Bioinformatics 21 (5), 676–679.
Posada, D., Buckley, T.R., 2004. Model selection and model averaging in
phylogenetics: advantages of Akaike Information Criterion and Bayesian
approaches over likelihood ratio tests. Syst. Biol. 53 (5), 793–808.
Posada, D., Crandall, K.A., 1998. MODELTEST: testing the model of DNA
substitution. Bioinformatics 14 (9), 817–818.
Posada, D., Crandall, K.A., 2001. Selecting models of nucleotide substitution:
an application to human immunodeficiency virus 1 (HIV-1). Mol. Biol.
Evol. 18 (6), 897–906.
Poss, M., Rodrigo, A.G., Gosink, J.J., Learn, G.H., de Vange Panteleeff, D.,
Martin Jr., H.L., Bwayo, J., Kreiss, J.K., Overbaugh, J., 1998. Evolution of
envelope sequences from the genital tract and peripheral blood of women
infected with clade A human immunodeficiency virus type 1. J. Virol. 72
(10), 8240–8251.
Rodrigo, A.G., Goracke, P.C., Rowhanian, K., Mullins, J.I., 1997. Quantitation
of target molecules from polymerase chain reaction-based limiting dilution
assays. AIDS Res. Hum. Retroviruses 13, 737–742.
Salvatori, F., Masiero, S., Giaquinto, C., Wade, C.M., Brown, A.J.L., Chieco-
Bianchi, L., Rossi, A.d., 1997. Evolution of human immunodeficiency virus
type 1 in perinatally infected infants with rapid and slow progression to
disease. J. Virol. 71, 4694–4706.
Shankarappa, R., Gupta, P., Learn, J., Rodrigo, G.H., Rinaldo Jr., G.,
Gorry, C.R., Mullins, M.C., Nara, J.I., Ehrlich, P.L., 1998. Evolution of
human immunodeficiency virus type 1 envelope sequences in infected
individuals with differing disease progression profiles. Virology 241,
251–259.
Shankarappa, R., Margolick, J.B., Gange, S.J., Rodrigo, A.G., Upchurch, D.,
Farzadegan, H., Gupta, P., Rinaldo, C.R., Learn, G.H., He, X., Huang, X.L.,
Mullins, J.I., 1999. Consistent viral evolutionary changes associated with the
303G. Bello et al. / Virology 362 (2007) 294–303progression of human immunodeficiency virus type 1 infection. J. Virol. 73
(12), 10489–10502.
Shioda, T., Oka, S., Xin, X., Liu, H., Harukuni, R., Kurotani, A., Fukushima,
M., Hasan, M.K., Shiino, T., Takebe, Y., Iwamoto, A., Nagai, Y., 1997. In
vivo sequence variability of human immunodeficiency virus type 1 envelope
gp120: association of V2 extension with slow disease progression. J. Virol.
71 (7), 4871–4881.
Simmonds, P., Zhang, L.Q., McOmish, F., Balfe, P., Ludlam, C.A., Brown,
A.J.L., 1991. Discontinuous sequence change of human immunodeficiency
virus (HIV) type 1 env sequences in plasma viral and lymphocyte-associated
proviral populations in vivo; implications for models of HIV pathogenesis. J.
Virol. 65, 6266–6276.
Strunnikowa, N., Ray, S.C., Livingston, R.A., Rubalcaba, E., Viscidi, R.P.,
1995. Convergent evolution within the V3 loop domain of human
immunodeficiency virus type 1 in association with disease progression.
J. Virol. 69, 7548–7558.
Thompson, J.D., Higgins, D.G., Gibson, T.J., 1994. CLUSTAL W: improving
the sensitivity of progressive multiple sequence alignment through sequence
weighting, position-specific gap penalties and weight matrix choice. Nucleic
Acids Res. 22 (22), 4673–4680.
Troyer, R.M., Collins, K.R., Abraha, A., Fraundorf, E., Moore, D.M., Krizan,
R.W., Toossi, Z., Colebunders, R.L., Jensen, M.A., Mullins, J.I., Vanham,
G., Arts, E.J., 2005. Changes in human immunodeficiency virus type 1fitness and genetic diversity during disease progression. J. Virol. 79 (14),
9006–9018.
Wang, B., Dyer, W.B., Zaunders, J.J., Mikhail, M., Sullivan, J.S., Williams, L.,
Haddad, D.N., Harris, G., Holt, J.A., Cooper, D.A., Miranda-Saksena, M.,
Boadle, R., Kelleher, A.D., Saksena, N.K., 2002. Comprehensive analyses
of a unique HIV-1-infected nonprogressor reveal a complex association of
immunobiological mechanisms in the context of replication-incompetent
infection. Virology 304 (2), 246–264.
Wei, X., Ghosh, S.K., Taylor, M.E., Johnson, V.A., Emini, E.A., Deutsch, P.,
Lifso, J.D., Bonhoeffer, S., Nowak, M.A., Hahn, B.H., Saag, M.S., Shaw,
G.M., 1995. Viral dynamics in human immunodeficiency virus type 1
infection. Nature 373, 117–122.
Williamson, S., Perry, S.M., Bustamante, C.D., Orive, M.E., Stearns, M.N.,
Kelly, J.K., 2005. A statistical characterization of consistent patterns of
human immunodeficiency virus evolution within infected patients. Mol.
Biol. Evol. 22 (3), 456–468.
Wolinsky, S.M., Korber, B.T.M., Neuman, A.U., Daniels, M., Kunstman, K.J.,
Whetsell, A.J., Furtado, M.R., Cao, Y., Ho, D.D., Safrit, J.T., Koup, R.A.,
1996. Adaptive evolution of human immunodeficiency virus type 1 during
the natural course of infection. Science 272, 537–542.
Zhang, L., Díaz, R.S., Ho, D.D., Mosley, J.W., Busch, M.P., Mayer, A., 1997.
Host-specific driving force in human immunodeficiency virus type 1
evolution in vivo. J. Virol. 71, 2555–2561.
